Human Reproductive Technologies

PUBLISHED: January 1, 2023

PAGES: 167 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Description

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Human Reproductive Technologies Market to Reach $34.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Human Reproductive Technologies estimated at US$28.9 Billion in the year 2022, is projected to reach a revised size of US$34.6 Billion by 2030, growing at aCAGR of 2.3% over the period 2022-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is projected to record 2.6% CAGR and reach US$22 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Infertility Treatment segment is readjusted to a revised 1.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.9 Billion, While China is Forecast to Grow at 3.9% CAGR

The Human Reproductive Technologies market in the U.S. is estimated at US$7.9 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Select Competitors (Total 12 Featured):

Ansell Healthcare LLC
Ansell Ltd.
Apothecus Pharmaceutical Corporation
Bayer AG
Cipla Ltd.
Ferring Pharmaceuticals, Inc.
Indian Drugs & Pharmaceuticals Ltd.
Janssen Pharmaceuticals, Inc.
Johnson & Johnson
Lupin Ltd.
Mankind Pharma Ltd.
Mapa GmbH
Merck & Co., Inc.
Merck KGaA
Pfizer, Inc.
The Female Health Company (FC2)
T-MARC Tanzania

Product Code: MCP-7916

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Human Reproductive Technologies - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 2: World Historic Review for Human Reproductive Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 3: World 18-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Contraceptive Drugs & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 5: World Historic Review for Contraceptive Drugs & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 6: World 18-Year Perspective for Contraceptive Drugs & Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Infertility Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 8: World Historic Review for Infertility Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 9: World 18-Year Perspective for Infertility Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
- TABLE 10: World Human Reproductive Technologies Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- TABLE 11: USA Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 12: USA Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 13: USA 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
CANADA
- TABLE 14: Canada Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 15: Canada Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 16: Canada 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
JAPAN
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- TABLE 17: Japan Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 18: Japan Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 19: Japan 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
CHINA
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- TABLE 20: China Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 21: China Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 22: China 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
EUROPE
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- TABLE 23: Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 24: Europe Historic Review for Human Reproductive Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 25: Europe 18-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
- TABLE 26: Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 28: Europe 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
FRANCE
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- TABLE 29: France Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 30: France Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 31: France 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
GERMANY
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- TABLE 32: Germany Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 33: Germany Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 34: Germany 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
ITALY
- TABLE 35: Italy Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 36: Italy Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 37: Italy 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
UNITED KINGDOM
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- TABLE 38: UK Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 39: UK Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 40: UK 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
SPAIN
- TABLE 41: Spain Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 42: Spain Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 43: Spain 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
RUSSIA
- TABLE 44: Russia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 45: Russia Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 46: Russia 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
REST OF EUROPE
- TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 48: Rest of Europe Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 49: Rest of Europe 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
ASIA-PACIFIC
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 51: Asia-Pacific Historic Review for Human Reproductive Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 52: Asia-Pacific 18-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 55: Asia-Pacific 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
AUSTRALIA
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
- TABLE 56: Australia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 57: Australia Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 58: Australia 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
INDIA
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
- TABLE 59: India Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 60: India Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 61: India 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
SOUTH KOREA
- TABLE 62: South Korea Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 63: South Korea Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 64: South Korea 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
REST OF ASIA-PACIFIC
- TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 66: Rest of Asia-Pacific Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 67: Rest of Asia-Pacific 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
LATIN AMERICA
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
- TABLE 68: Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 69: Latin America Historic Review for Human Reproductive Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 70: Latin America 18-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 73: Latin America 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
ARGENTINA
- TABLE 74: Argentina Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 75: Argentina Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 76: Argentina 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
BRAZIL
- TABLE 77: Brazil Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 78: Brazil Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 79: Brazil 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
MEXICO
- TABLE 80: Mexico Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 81: Mexico Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 82: Mexico 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
REST OF LATIN AMERICA
- TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 84: Rest of Latin America Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 85: Rest of Latin America 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
MIDDLE EAST
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
- TABLE 86: Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 87: Middle East Historic Review for Human Reproductive Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 88: Middle East 18-Year Perspective for Human Reproductive Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
- TABLE 89: Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 90: Middle East Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 91: Middle East 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
IRAN
- TABLE 92: Iran Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 93: Iran Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 94: Iran 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
ISRAEL
- TABLE 95: Israel Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 96: Israel Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 97: Israel 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
SAUDI ARABIA
- TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 99: Saudi Arabia Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 100: Saudi Arabia 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
UNITED ARAB EMIRATES
- TABLE 101: UAE Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 102: UAE Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 103: UAE 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
REST OF MIDDLE EAST
- TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 105: Rest of Middle East Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 106: Rest of Middle East 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030
AFRICA
- Human Reproductive Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
- TABLE 107: Africa Recent Past, Current & Future Analysis for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 108: Africa Historic Review for Human Reproductive Technologies by Technology - Contraceptive Drugs & Devices and Infertility Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
- TABLE 109: Africa 18-Year Perspective for Human Reproductive Technologies by Technology - Percentage Breakdown of Value Sales for Contraceptive Drugs & Devices and Infertility Treatment for the Years 2012, 2023 & 2030